Fiamma Berner

1.3k total citations
11 papers, 459 citations indexed

About

Fiamma Berner is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Fiamma Berner has authored 11 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 4 papers in Immunology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Fiamma Berner's work include Cancer Immunotherapy and Biomarkers (10 papers), Lung Cancer Treatments and Mutations (3 papers) and Immune Cell Function and Interaction (3 papers). Fiamma Berner is often cited by papers focused on Cancer Immunotherapy and Biomarkers (10 papers), Lung Cancer Treatments and Mutations (3 papers) and Immune Cell Function and Interaction (3 papers). Fiamma Berner collaborates with scholars based in Switzerland, Germany and Austria. Fiamma Berner's co-authors include Lukas Flatz, Stefan Diem, Omar Hasan Ali, David Bomze, Mirjam Fässler, Antonio Cozzio, Tobias L. Lenz, Martin Früh, Christoph Driessen and Jennifer Lippincott‐Schwartz and has published in prestigious journals such as The Journal of Cell Biology, Immunological Reviews and Annals of Oncology.

In The Last Decade

Fiamma Berner

10 papers receiving 456 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fiamma Berner Switzerland	7	284	120	90	88	71	11	459
Nataliya V. Uboha United States	15	326 1.1×	70 0.6×	182 2.0×	35 0.4×	143 2.0×	69	588
Junfeng Wu China	14	149 0.5×	190 1.6×	252 2.8×	75 0.9×	26 0.4×	26	547
Alison Kraus Germany	11	130 0.5×	93 0.8×	284 3.2×	59 0.7×	78 1.1×	18	473
Peiwen Kuo United States	8	99 0.3×	93 0.8×	179 2.0×	49 0.6×	34 0.5×	16	370
Catharina Conrad Germany	11	209 0.7×	62 0.5×	190 2.1×	21 0.2×	82 1.2×	18	501
Ya‐Chin Hou Taiwan	12	199 0.7×	133 1.1×	262 2.9×	33 0.4×	50 0.7×	21	508
Naita M. Wirsik Germany	9	220 0.8×	91 0.8×	143 1.6×	98 1.1×	59 0.8×	22	443
Reika Kawabata‐Iwakawa Japan	14	271 1.0×	169 1.4×	296 3.3×	20 0.2×	81 1.1×	59	601
M Siena Italy	9	101 0.4×	142 1.2×	162 1.8×	57 0.6×	17 0.2×	11	400
M. Taton Belgium	10	180 0.6×	59 0.5×	332 3.7×	93 1.1×	75 1.1×	17	635

Countries citing papers authored by Fiamma Berner

Since Specialization

Citations

This map shows the geographic impact of Fiamma Berner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fiamma Berner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fiamma Berner more than expected).

Fields of papers citing papers by Fiamma Berner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fiamma Berner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fiamma Berner. The network helps show where Fiamma Berner may publish in the future.

Co-authorship network of co-authors of Fiamma Berner

This figure shows the co-authorship network connecting the top 25 collaborators of Fiamma Berner. A scholar is included among the top collaborators of Fiamma Berner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fiamma Berner. Fiamma Berner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Flatz, Lukas, M. Frueh, Stefan Diem, et al.. (2023). 1016O Autoimmunity against surfactant protein B drives immune checkpoint inhibitor-related pneumonitis in patients with NSCLC. Annals of Oncology. 34. S619–S619.

Berner, Fiamma & Lukas Flatz. (2023). Autoimmunity in immune checkpoint inhibitor‐induced immune‐related adverse events: A focus on autoimmune skin toxicity and pneumonitis. Immunological Reviews. 318(1). 37–50. 15 indexed citations

Klümper, Niklas, Fiamma Berner, Annkristin Heine, et al.. (2022). C reactive protein flare predicts response to checkpoint inhibitor treatment in non-small cell lung cancer. Journal for ImmunoTherapy of Cancer. 10(3). e004024–e004024. 53 indexed citations

Purde, Mette-Triin, Rebekka Niederer, Nikolaus B. Wagner, et al.. (2021). Presence of autoantibodies in serum does not impact the occurrence of immune checkpoint inhibitor-induced hepatitis in a prospective cohort of cancer patients. Journal of Cancer Research and Clinical Oncology. 148(3). 647–656. 11 indexed citations

Ali, Omar Hasan, Fiamma Berner, Christoph Ackermann, et al.. (2020). Fingolimod and tumor-infiltrating lymphocytes in checkpoint-inhibitor treated cancer patients. Cancer Immunology Immunotherapy. 70(2). 563–568. 6 indexed citations

Ali, Omar Hasan, David Bomze, Sandra S. Ring, et al.. (2019). BP180-specific IgG is associated with skin adverse events, therapy response, and overall survival in non-small cell lung cancer patients treated with checkpoint inhibitors. Journal of the American Academy of Dermatology. 82(4). 854–861. 76 indexed citations

Berner, Fiamma, David Bomze, & Lukas Flatz. (2019). Immune-Related Adverse Events of Immune Checkpoint Inhibitors—From a Clinical to Pathophysiological View—In Reply. JAMA Oncology. 5(12). 1805–1805. 5 indexed citations

Diem, Stefan, Mirjam Fässler, David Bomze, et al.. (2019). Immunoglobulin G and Subclasses as Potential Biomarkers in Metastatic Melanoma Patients Starting Checkpoint Inhibitor Treatment. Journal of Immunotherapy. 42(3). 89–93. 24 indexed citations

Diem, Stefan, Mirjam Fässler, Omar Hasan Ali, et al.. (2018). Risk score for non-small cell lung cancer patients starting checkpoint inhibitor treatment. Cancer Management and Research. Volume 10. 5537–5544. 2 indexed citations

10.

Ali, Omar Hasan, Fiamma Berner, David Bomze, et al.. (2018). Human leukocyte antigen variation is associated with adverse events of checkpoint inhibitors. European Journal of Cancer. 107. 8–14. 143 indexed citations

11.

Allison, Rachel, James R. Edgar, Tania Rizo, et al.. (2017). Defects in ER–endosome contacts impact lysosome function in hereditary spastic paraplegia. The Journal of Cell Biology. 216(5). 1337–1355. 124 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact